 - link Copy URL
- [     Share on X ](https://twitter.com/intent/tweet?text=The Key to Fighting Chronic Disease in South-East Asia: Young People https://www.3blmedia.com/markdownify/node/81562?absolute=1&via=3blnews "Share on X")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/81562?absolute=1 "Share on Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/81562?absolute=1 "Share on Facebook")
- [ email Share via email ](mailto:?subject=The Key to Fighting Chronic Disease in South-East Asia: Young People&body=ESG News from Novartis https://www.3blmedia.com/markdownify/node/81562?absolute=1 "Share via email")
 
 

 [Health &amp; Healthcare](/categories/health-healthcare)

 # The Key to Fighting Chronic Disease in South-East Asia: Young People

 

##### More than half the ASEAN region’s 630 million people are under age 30. Harald Nusser, Head of Novartis Social Business, says that to fight the rise of chronic disease in South East Asia we need to inform its youth on the importance of healthy lifestyles.

 

 

 May 10, 2017 1:00 PM ET

  Campaign:  [Novartis Access: Medicines to treat chronic diseases in lower-income countries ](/news/campaign/novartis-access-medicines-treat-chronic-diseases-lower-income-countries)  ![](https://3blcdn.com/styles/carousel_2x/s3/2026-08/NovartisVietnam_0053_sm_1786910541.jpg)

 

[The key to fighting chronic disease in South-East Asia - young people](https://www.weforum.org/agenda/2017/05/we-need-to-recruit-south-east-asia-s-youth-in-the-fight-against-chronic-disease/)

Increasing longevity, urbanization and poor lifestyles are contributing to a massive increase in non-communicable diseases (NCDs) in South-East Asia. According to the World Health Organization,[ ](http://www.searo.who.int/entity/noncommunicable_diseases/events/ncd_workshop_2014_regional_burden_of_ncds.pdf)[55% of all deaths](http://www.searo.who.int/entity/noncommunicable_diseases/events/ncd_workshop_2014_regional_burden_of_ncds.pdf) in the region are due to NCDs – that is nearly 8 million people every year. More worryingly, one-third of those dying as a result of NCDs are younger than 60. Such premature mortality causes immense social and economic loss.



The growth in NCDs has also led to a “dual burden of disease” for these countries – having to transform health systems built to fight infectious diseases and provide acute care to ones which can manage the silent epidemic of chronic diseases like diabetes, heart disease, respiratory illnesses and cancer. What are the policy and operational implications of addressing this dual burden?



Four important aspects stand out. The first is health systems integration. Many infectious disease programmes were developed in so-called “vertical” formats, with different silos for diseases like HIV/AIDS, TB and malaria. These now need to be integrated in order to provide care across diseases, beyond specific conditions with a patient rather than just a disease focus. An example is HIV, where the need for long-term antiretroviral treatment has led to the upgrade of supply chains to minimize stock-outs in lower-income countries. Similarly, treatments for chronic disease require well-managed supply chains.



Continue reading here on the WEF blog: <https://www.weforum.org/agenda/2017/05/we-need-to-recruit-south-east-asia-s-youth-in-the-fight-against-chronic-disease/>



 

 

 

 

 

 

 

 [![Novartis logo](/sites/default/files/Clients/novartis_logo_012919.jpg)](/profiles/novartis)

 

 

### More from Novartis

###### [Energize – A First-of-Its-Kind Program to Increase Access to Renewable Energy for Pharmaceutical Suppliers](/news/energize-first-its-kind-program-increase-access-renewable-energy-pharmaceutical-suppliers)

 Nov 4, 2021 6:00 AM ET

  



###### [Novartis and Medicines for Malaria Venture Report Positive Results for Phase 2b Study of Novel Ganaplacide/Lumefantrine Combination in Children With Malaria](/news/novartis-and-medicines-malaria-venture-report-positive-results-phase-2b-study-novel)

 Sep 29, 2021 3:00 PM ET

  



###### [Together Against Child Mortality: Novartis and Save the Children Launch Health Project in the Slums of Nairobi](/news/together-against-child-mortality-novartis-and-save-children-launch-health-project-slums)

 Aug 2, 2021 9:00 AM ET

  



###### [Novartis Pledges 10-year Commitment With Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and Other Leading Organizations to Co-create Effective, Measurable Solutions for Health Equity](/news/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges)

 Jul 20, 2021 8:15 AM ET

  



###### [Novartis and Hewlett Packard Enterprise Join Forces to Advance Novartis Global Health Efforts](/news/novartis-and-hewlett-packard-enterprise-join-forces-advance-novartis-global-health-efforts)

 Jun 23, 2021 12:10 PM ET

  



###### [Novartis Reaches Milestone Delivery of 1 Billion Courses of Antimalarial Treatment](/news/novartis-reaches-milestone-delivery-1-billion-courses-antimalarial-treatment)

 May 18, 2021 2:15 AM ET

  



###### [Novartis Inaugurates Innovative Watershed Project in India to Increase Water Availability](/news/novartis-inaugurates-innovative-watershed-project-india-increase-water-availability)

 Mar 22, 2021 10:30 AM ET

  



###### [Novartis and the Bill &amp; Melinda Gates Foundation Collaborate to Discover and Develop an Accessible in Vivo Gene Therapy for Sickle Cell Disease](/news/novartis-and-bill-melinda-gates-foundation-collaborate-discover-and-develop-accessible-vivo)

 Feb 17, 2021 1:15 AM ET